Statins in the treatment of autosomal dominant polycystic kidney disease

被引：6

作者：

Ecder, Tevfik ^{[1
]}

机构：

[1] Istanbul Bilim Univ, Div Nephrol, Dept Internal Med, Fac Med, Istanbul, Turkey

来源：

NEPHROLOGY DIALYSIS TRANSPLANTATION | 2016年 / 31卷 / 08期

关键词：

REDUCTASE INHIBITORS; ENDOTHELIAL FUNCTION; RENAL-FUNCTION; LOVASTATIN; SIMVASTATIN; PRAVASTATIN;

D O I：

10.1093/ndt/gfv449

中图分类号：

R3 [基础医学]; R4 [临床医学];

学科分类号：

1001 ; 1002 ; 100602 ;

摘要：

aEuro broken vertical bar Will statins take a place in the therapeutic armamentarium of ADPKD? We need large randomized controlled trials to give a clear answer to this question. Until we get this evidence, the decision to use a statin in the management of patients with ADPKD will remain with the physician.aEuro broken vertical bar.

引用

页码：1194 / 1196

页数：3

共 22 条

[11] Lovastatin preserves renal function in experimental diabetes [J].

Inman, SR ;

Stowe, NT ;

Cressman, MD ;

Brouhard, BH ;

Nally, JV ;

Satoh, S ;

Satodate, R ;

Vidt, DG .

AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1999, 317 (04) :215-221

[12] HMG-CoA reductase inhibition:: anti-inflammatory effects beyond lipid lowering? [J].

März, W ;

Köenig, W .

JOURNAL OF CARDIOVASCULAR RISK, 2003, 10 (03) :169-179

[13] Improvement of endothelial dysfunction with simvastatin in patients with autosomal dominant polycystic kidney disease [J].

Namli, Sule ;

Oflaz, Huseyin ;

Turgut, Farnk ;

Alisir, Sabahat ;

Tufan, Fatih ;

Ucar, Adem ;

Mercanoglu, Fehmi ;

Ecder, Tevfik .

RENAL FAILURE, 2007, 29 (01) :55-59

[14] Autosomal dominant polycystic kidney disease: the changing face of clinical management [J].

Ong, Albert C. M. ;

Devuyst, Olivier ;

Knebelmann, Bertrand ;

Walz, Gerd .

LANCET, 2015, 385 (9981) :1993-2002

[15] Blood Pressure in Early Autosomal Dominant Polycystic Kidney Disease [J].

Schrier, Robert W. ;

Abebe, Kaleab Z. ;

Perrone, Ronald D. ;

Torres, Vicente E. ;

Braun, William E. ;

Steinman, Theodore I. ;

Winklhofer, Franz T. ;

Brosnahan, Godela ;

Czarnecki, Peter G. ;

Hogan, Marie C. ;

Miskulin, Dana C. ;

Rahbari-Oskoui, Frederic F. ;

Grantham, Jared J. ;

Harris, Peter C. ;

Flessner, Michael F. ;

Bae, Kyongtae T. ;

Moore, Charity G. ;

Chapman, Arlene B. .

NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (24) :2255-2266

[16] Autosomal dominant polycystic kidney disease [J].

Torres, Vicente E. ;

Harris, Peter C. ;

Pirson, Yves .

LANCET, 2007, 369 (9569) :1287-1301

[17] Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease [J].

Torres, Vicente E. ;

Chapman, Arlene B. ;

Devuyst, Olivier ;

Gansevoort, Ron T. ;

Grantham, Jared J. ;

Higashihara, Eiji ;

Perrone, Ronald D. ;

Krasa, Holly B. ;

Ouyang, John ;

Czerwiec, Frank S. .

NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (25) :2407-2418

[18] Cerivastatin, a hydroxymethylglutaryl coenzyme A reductase inhibitor, improves endothelial function in elderly diabetic patients within 3 days [J].

Tsunekawa, T ;

Hayashi, T ;

Kano, H ;

Sumi, D ;

Matsui-Hirai, H ;

Thakur, NK ;

Egashira, K ;

Iguchi, A .

CIRCULATION, 2001, 104 (04) :376-379

[19] Effect of simvastatin on renal function in autosomal dominant polycystic kidney disease [J].

van Dijk, MA ;

Kamper, AM ;

van Veen, S ;

Souverijn, JHM ;

Blauw, GJ .

NEPHROLOGY DIALYSIS TRANSPLANTATION, 2001, 16 (11) :2152-2157

[20] Effect of statin and angiotensin-converting enzyme inhibition on structural and hemodynamic alterations in autosomal dominant polycystic kidney disease model [J].

Zafar, Iram ;

Tao, Yunxia ;

Falk, Sandor ;

McFann, Kimberly ;

Schrier, Robert W. ;

Edelstein, Charles L. .

AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2007, 293 (03) :F854-F859

← 1 2 3 →